Genprex Inc (GNPX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.13
• Market Cap: $6.76M
• P/E Ratio: 0.10
• EPS: $42.50
• 52-Week High: $55.00
• 52-Week Low: $1.71

Market Sentiment

Genprex Inc currently has a Bullish sentiment score of 0.37.

About Genprex Inc

Genprex, Inc. is a clinical-stage gene therapy company based in Austin, Texas, dedicated to developing groundbreaking therapies aimed at treating cancer and diabetes. Their innovative approach leverages unique gene therapies to address unmet medical needs, with a focus on improving patient outcomes in difficult-to-treat diseases. As a pioneer in the gene therapy space, Genprex is actively advancing its pipeline of therapies through rigorous clinical trials, positioning itself at the forefront...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Genprex Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GNPX pay dividends?

Genprex Inc (GNPX) does not currently pay a regular dividend.

What is GNPX's P/E ratio?

Genprex Inc has a price-to-earnings (P/E) ratio of 0.10.

What is GNPX's market cap?

Genprex Inc (GNPX) has a market capitalization of $6.76M with a current stock price of $2.13.